logo
Plus   Neg
Share
Email
Comment

4SC Receives Key Patent For Oncology Compound Resminostat In Japan

4SC AG (FSCGF.PK) Wednesday said it has been granted a key patent for its lead anti-cancer compound resminostat in Japan. The patent covers the composition of matter of resminostat, pharmaceutical compositions comprising resminostat and its therapeutic use in cancer and other therapeutic areas.

The company is engaged in the discovery and development of targeted small molecule drugs for autoimmune diseases and cancer. In April, 4SC granted an exclusive license to Yakult Honsha for the development and commercialization of resminostat in Japan. Hepatocellular carcinoma, the most common type of liver cancer, has a particularly high incidence in Japan.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google plans to commission three underwater cables in 2019 as part of efforts to expand its cloud business amid stiff competition from rivals Microsoft and Amazon. The three fiber-optic subsea cables will run across different routes. Google noted that it has spent $30 billion to improve its infrastructure over three years. McDonald's Corp. said Tuesday that all of its packaging worldwide will come from renewable, recycled or certified sources by 2025, up from the current figure of 50 percent. The fast food giant also aims to recycle guest packaging in all its restaurants by then, compared with only 10 percent of its restaurants currently. General Electric Co. (GE) will take an after-tax charge of $6.2 billion in its fourth quarter results as part of comprehensive review of its finance arm's insurance portfolio. The after-tax charge will be $7.5 billion when adjusted to the rate following the recent U.S. tax overhaul.
comments powered by Disqus
Follow RTT